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Summary 
Newly made polypeptide chains not only require the help of molecular chaperones 
to rapidly reach their final three-dimensional forms, but also to unfold and then 
correctly refold them back to their biologically active form should  they misfold. 
Most prions are an unusual class of protein that can exist in one of two stable 
conformations, one of which leads to formation of an infectious alternatively folded 
form.  Studies in Baker’s yeast (Saccharomyces cerevisiae) have revealed that prions 
can exploit the molecular chaperone machinery in the cell in order to ensure stable 
propagation of the infectious, aggregation-prone form. The disaggregation of yeast 
prion aggregates by molecular chaperones generates forms of the prion protein that 
can seed the protein polymerisation that underlies the prion propagation cycle. In 
this article we review what we have learnt about the role of molecular chaperones in 
yeast prion propagation, describe a model to that can explain the role of various 
classes of molecular chaperones and their co-chaperones, and speculate on the 




The information necessary for a protein to fold into its native three-dimensional  form is 
contained within the primary amino acid sequence of the polypeptide chain  (1). As the 
polypeptide chain emerges from the ribosome, possibly even before its synthesis is 
complete, it will begin to transition through one, possibly more, partially structured states 
before arriving at the biologically active, pre-ordained structure. Protein folding cannot 
occur in a random, unbiased manner where all possible combinations are explored in 
order to reach the final structure; the so-called Levinthal Paradox. Rather, each protein 
species appears to have evolved a conserved and simplified pathway of folding (2; 
review). 
 
In order to help a protein reach its final form and avoid going ‘off-pathway’ and misfold, 
many proteins call on the assistance of a number of cellular ‘chaperone’ proteins (3: 
review). The primary role of protein chaperones is to catalyse protein folding and they 
achieve this by interacting non-covalently with the nascent polypeptide chain in order to 
stabilize the encrypted folds and thereby prevent non-productive reactions that might lead 
to an incorrectly folded structure. In other words, by lowering the activation barrier 
between the partially folded structure and the native form, chaperones accelerate the 
desired folding steps thereby ensuring that the encrypted folding instructions are 
faithfully adhered to. 
 
Chaperones are also required to rescue proteins that, as a consequence of having deviated 
from their desired folding pathway, have become misfolded and aggregated. This can 
 3
arise spontaneously or as a consequence of a cell being subject to environmental stresses 
such as heat shock. Specific chaperones unfold the misfolded or aggregated protein and, 
in conjunction with other chaperones, rescue the protein by sequential unfolding and 
refolding the protein back to its native and biologically active form. 
 
Although the primary role of chaperones is to prevent protein misfolding and 
aggregation, an unusual class of proteins found in both mammals and fungi have 
apparently evolved to exploit the molecular chaperone machinery to remodel their 
conformation into an aggregation-prone, infectious form; the so-called prion proteins (4). 
Once the alternatively (mis)folded structure of a prion protein is established, it becomes 
self-propagating and can be transmitted from cell to cell usually in the form of protease-
resistant fibres that are characteristically rich in β-sheets. The presence of amyloid 
protein aggregates is a characteristic of a number of non-transmissible neurodegenerative 
diseases such as Huntington’s Disease and Alzheimer’s Disease (5). 
 
While the mammalian prion protein PrP (in its protease-resistant form PrPSc) is widely 
recognised as the causative agent of mammalian Transmissible Spongiform 
Encephalopathies (TSEs) such as CJD and BSE (6), the prions found in fungi are not 
necessarily detrimental to the host cell. For example, the [Het-s] prion is required for 
heterokaryon incompatibility in Podospora anserina (7) and is found in a large 
proportion of isolates of this fungus. In some cases therefore, prions may actually be of 
benefit to the host cell by acting as epigenetic regulators of cell phenotype (8).  
 4
Important new insights into the role(s) played by molecular chaperones in the 
propagation of fungal prions are now beginning to emerge from both genetic and 
biochemical studies particularly with the yeast Saccharomyces cerevisiae. In this review 
we will first provide an overview of yeast’s molecular chaperone machinery before 
considering what we have learned about the role chaperones play in prion propagation in 
fungi and possibly higher eukaryotes. 
 
Molecular chaperones and protein folding in the yeast cell 
The unicellular eukaryote S. cerevisiae has proven to be an invaluable tool for elucidating 
protein folding pathways within the cytosol of a eukaryotic cell. All the major classes of 
chaperone implicated in such pathways have also been identified and extensively 
characterized in yeast (Table 1). For the majority of identified yeast molecular 
chaperones, human homologues have also been identified, but with one notable exception 
– no homologue of the Hsp104 chaperone has yet been described in mammals although a 
homologue is found in plants (9). The main classes of chaperones in the eukaryotic 
cytosol are generally classified as heat shock proteins (Hsps) because their synthesis is 
induced by conditions (such as heat shock) that trigger protein misfolding and 
aggregation although not all chaperones are Hsps. 
 
The major class of chaperones belong to the Hsp70 family, a diverse collection of 70 kDa 
chaperones that exist in various compartments of the cell. The main Hsp70 component of 
the yeast cytosol is the Ssa family (Stress seventy subfamily A) comprising of the four 
closely related proteins Ssa1-4 and which collectively provide an essential cellular 
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function. The Ssa proteins are involved in various aspects of protein folding working in 
conjunction with other chaperones (10, a review). Other Hsp70s in yeast include the 
ribosome-bound Ssb and Ssz proteins and the cytosolic Sse proteins (Table 1)  which 
collectively, carry out an array of protein folding functions that ensure correct folding of 
nascent polypeptides, prevent aggregation of denatured or partially unfolded proteins and, 
in some cases, facilitate correct sub-cellular localisation.  
 
Yeast has two members of the Hsp90 class of chaperones; the heat-shock inducible 
Hsp82 and the constitutively expressed Hsc82. These two proteins are functionally 
redundant, but in combination provide an essential cellular function (11). The Hsp90s 
work in conjunction with Hsp70 and a host of other co-chaperones to facilitate the correct 
folding and maturation of an array of proteins (10). In mammalian cells, the Hsp90 
chaperone machinery facilitates the correct folding of key regulatory proteins such as 
steroid hormone receptors, transcription factors and protein kinases (10,11) although the 
‘client list’ for yeast Hsp90s is less well defined. The high degree of conservation of the 
Hsp70-Hsp90 chaperone machinery between yeast and mammals, including co-factor 
requirements, illustrates the value of using a model organism such as S. cerevisiae to gain 
real insights into protein folding in the eukaryotic cell. 
 
The yeast chaperone that appears to have no mammalian homologue, Hsp104, is a 
member of the AAA+ superfamily of ATPases and is similar in both sequence and 
function to the E. coli ClpB protease (12). Although not essential for cell viability, 
Hsp104 plays a critical role in ensuring that cells subjected to prolonged exposure to 
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physical (e.g high temperatures) or chemical (e.g. ethanol) stresses, are able to survive. 
Unlike Hsp70 and other chaperones such as the small heat shock proteins (sHsps, Table 
1), this role is not to prevent the aggregation of denatured or partially unfolded proteins, 
but rather, in conjunction with both Hsp70 and the co-chaperone Hsp40, to act as a 
protein ‘disaggregase’ leading to the resolubilisation of protein aggregates (13). Hsp104 
acts as a molecular ‘crowbar’ to shear high molecular weight aggregates into smaller 
aggregates that can then be more effectively dealt with by the Hsp70/Hsp40 chaperone 
system (Figure 1). In so doing, Hsp104 acts in a similar manner proposed for the bacterial 
ClpB/DnaK chaperones (14,15). As with prokaryotes, yeast therefore has evolved 
complimentary systems to either prevent non-productive protein aggregation or to rescue 
proteins that have become aggregated. It is yet to be established if such systems are 
present in mammalian cells although proteins such as p97/VCP/Cdc48 share both 
sequence and functional similarities with Hsp104 (see below). The existence of an 
Hsp104 homologue in plants (9) raises the possibility that a search for prions in 
genetically tractable plants such as Arabidopsis may bare fruit. 
 
In the yeast cell, as in other eukaryotes, a number of co-chaperones and co-factors can 
modulate the functions of the Hsp70 and Hsp90 proteins (Table 1). The Hsp40 co-
chaperones directly interact with both Hsp70 and Hsp90 to modify their function, 
although their main function is to bind unfolded proteins and to present these substrates 
to their relative Hsp70 partner. In other words, Hsp40s can act both as chaperones and as 
co-chaperones. Also important in the regulation of the ATPase activity of the Hsp70-
Hsp90 chaperone machinery are co-chaperones that possess the tetratricopeptide repeat 
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(TPR) motif (16). The identity of the co-chaperones present within the Hsp70-Hsp90 
complex will usually reflect the level of maturation of a particular peptide substrate (10, 
review). The Hsp90 co-chaperones Sti1p, Cpr7p and Cns1p also bind to Hsp104 under 
certain physiological conditions, although how this co-chaperone interaction modulates 
Hsp104 function remains to be established (17). 
 
A specialised cytosolic chaperone machine is also present in both yeast and higher 
eukaryotic cells, namely CCT (cytosolic chaperonin containing T-complex polypeptide-
1) or TriC (tailless complex polypeptide- 1 [TCP-1] ring complex) which belongs to the 
same class of chaperones as the bacterial GroEL/ES chaperonin (18). CCT has 8 different 
sub-units which form a heteromeric complex of two stacked rings and acts primarily to 
fold actins and tubulins (18). The CCT rings undergo an ATPase-dependent 
conformational change when bound to their relatively limited repertoire of substrates and 
provide an enclosed environment for polypeptides to fold correctly in. In terms of both 
form and function, the CCT complex is highly conserved between yeast and humans 
(18,19).  
 
Hsp26 and Hsp42 are two low molecular weight chaperones within the yeast cytosol 
(Table 1) that function independently to prevent the non-specific aggregation of about 
30% of the cytosolic protein species (20,21). As with the CCT complex, both Hsp26 and 
Hsp42 form oligomeric structures, but these are homopolymeric rather than 
heteropolymeric in nature (20,24). Only the synthesis of Hsp26 is induced by thermal 
stress while Hsp42 represents the major cellular chaperone in non-stressed cells (21). 
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 What happens when a cell finds itself hosting and propagating prion aggregates? 
Chaperones represent a first line of defense against the generation and accumulation of 
misfolded, potentially toxic, protein aggregates. Yet, the very fact that prions are 
remarkably effective at self-propagation, would suggest that the prion aggregates have 
not only evolved features to avoid the disaggregation and refolding activities of the 
chaperone machinery, but can also avoid the back-up defense of degradation by the 
polyubiquitin/proteasome system (22). In fact, studies with yeast suggest that prions may 
have actually evolved to exploit the properties of the cellular chaperone machinery in 
order to propagate their infectious altered conformer. 
 
Yeast prions and their propagation 
S. cerevisiae has at least three proteins that meet the necessary genetic (23) and 
biochemical criteria (24) to be defined as a prion: Sup35p/[PSI+], Ure2p/[URE3+] and 
Rnq1p/[RNQ/PIN+]. Of these perhaps the best understood in terms of its chaperone 
requirement is the translation termination factor Sup35p. In its prion state, Sup35p 
aggregates giving rise to [PSI+] cells that show a defect in translation termination (25). In 
[PSI+] cells one usually finds greater than 90% of the Sup35p present in the form of a 
high molecular weight aggregate (26,27) although there are some natural ‘variants’ of 
[PSI+] where this figure is nearer 50% (28) and concomitantly, show a weaker 
termination phenotype. In contrast, in prion-free [psi-] cells >95% of the Sup35p is in a 
soluble functional form. 
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Critical for establishment and propagation of the [PSI+] prion aggregate is the prion-
forming domain (PrD) located at the N-terminus of Sup35p and separated from the 
essential release factor domain by a highly charged region called ‘M’ (29, review). Both 
Ure2p and Rnq1p also contain distinct regions that act as self-contained prion-forming 
domains (30,31). In vitro, the individual PrDs are able to spontaneously undergo 
conformational rearrangement in the absence of any other proteins or nucleic acids, to 
generate highly stable amyloid fibrils that show all the biophysical characteristics of the 
amyloid deposits in certain neurodegenerative diseases (32, review). Therefore, in spite 
of the presence of the protective mechanisms provided by the chaperones and the 
ubiquitin/proteasome systems, yeast prion-containing cells are able to carry and 
efficiently propagate high molecular weight aggregates that are absent from prion-free 
cells. Such aggregates can be readily visualised in both S.cerevisiae (26, 31,33) and 
Podospora (34) by fusing the respective prion protein to green fluorescent protein (GFP) 
and observing the appearance of fluorescent foci (Figure 2). Speransky et al (35) have 
also directly demonstrated that the presence of protein filaments in [URE3] strains that 
contain Ure2p although no direct evidence that any of the fungal prion proteins form 
amyloids in vivo has been forthcoming. 
 
The spontaneous conversion of Sup35p to its prion form occurs is less than one in 106 
cells suggesting that although the cell is not able to eliminate the prion once it is formed, 
nevertheless it has an effective mechanism to keep spontaneous prion protein conversion 
in check. The rate of such de novo conversion can be dramatically elevated by 
overexpressing the corresponding full-length prion protein or its isolated PrD (36) 
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provided the cells already have at least one other prion already resident in the same cell. 
Originally referred to as the [PIN] determinant - for Psi Inducibility (37) – we now know 
that [PIN] is commonly (but not exclusively) the prion form of Rnq1p (38,39). The 
requirement of a second prion for efficient prion conversion suggests that either the prion 
form of one protein can template the formation of a second, sequence-unrelated protein, 
but with amyloid-forming potential (38), or the [PIN] prion titrates out an endogenous 
inhibitor of prion conversion which may be one of the cytosolic chaperones (39). It is 
only the de novo conversion that requires [PIN] since once the [PSI+] prion is established, 
it can be stably propagated in the absence of [PIN] (37). 
 
Stable propagation of yeast prion aggregates requires not only the generation of new 
propagons (i.e. oligomeric prion ‘seeds’, 40) to drive soluble forms of the protein into 
prion aggregates, but also the propagons must be efficiently distributed during mitosis 
and meiosis. In yeast, propagon generation and transmission requires the molecular 
chaperone Hsp104 and thus plays an essential role in the propagation of all three native 
yeast prions (31,41,42). However, the structural features of the prion aggregates, or the 
propagons that seed their formation, remain to be established. The high molecular weight 
aggregates, as visualized by GFP fusions (Figure 2), may be the dead-end by-products of 
Sup35p aggregation. Exactly what constitutes a propagon at the molecular level, how its 
structure relates to the high molecular weight (amyloid-like) prion aggregates found in 
cells, and how the various chaperone proteins functionally interact to generate and 
transmit these unusual heritable units so effectively, remain important questions that, 
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through in vivo and in vitro studies (discussed below) we are at last beginning to 
understand. 
 
Do protein disaggregation and prion propagation go hand-in-hand? 
Yeast strains carrying a deletion of the HSP104 gene, although viable, are unable to 
propagate any of the three native yeast prions so far described (31,41,42). The 
requirement for Hsp104 is not however absolute because Sup35p chimaeras containing 
heterologous sequences in place of either the highly charged M region (43) or the PrD 
(44) can form transmissible prion aggregates that are propagated in the absence of 
Hsp104. 
 
Hsp104 is an ATPase and, like other members of the AAA+ protein superfamily  
mediates ATP-dependent unfolding/disassembly of protein-protein complexes and 
contains two AAA modules with motifs for ATP binding and hydrolysis (12, review). 
Inhibition of the ATPase activity of Hsp104 in vivo by 3 mM guanidine hydrochloride 
(GdnHCl) (45-47leads to a rapid block in the ability of the cell to generate new 
propagons resulting in the appearance, after 4 or 5 generations, of propagon-free i.e. 
[prion-] cells (46,48). 
 
The model that is most consistent with these data is that Hsp104 generates new [PSI+] 
propagons by disassembly of the high molecular weight prion aggregates, into smaller 
seeding competent oligomers (49,50) (see Figure 1). Inhibition of Hsp104 by GdnHCl 
does not block prion protein aggregation per se (51) but does lead to a block in the 
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fragmentation of Sup35p aggregates in vivo (52). This has lead to the proposal for a two-
cycle model for prionisation of Sup35p (and most likely, other yeast prions proteins): an 
Hsp104-dependent process that generates new propagons and an Hsp104-independent 
process that converts propagons into a high molecular weight, possibly non-seeding dead-
end product (51) (Figure 1). Consistent with this model, over expression of Hsp104 in 
exponentially growing [PSI+] cells also leads to a rapid loss of the [PSI+] prion (41) 
presumably by accelerating the disaggregation of Sup35p polymers that can then be 
efficiently dealt with by the Hsp40/70 chaperone system.  
 
The mechanism(s) by which either the absence of, or high levels of, Hsp104 can 
eliminate the [PSI+] prion has recently emerged from studies using a reconstituted in vitro 
fibrillisation assay based on recombinant Sup35pNM (53). In this assay low levels of 
Hsp104 catalyse the formation of relatively small oligomeric intermediates of Sup35pNM 
that are required for the nucleation of new fibrils in vitro. Critically, at higher 
concentrations, Hsp104 blocks the maturation of these oligomers into fibrils and 
promotes disassembly of the pre-existing fibrils into non-seeding species. To fully 
understand the consequences of manipulating Hsp104 levels on prion propagation in the 
cell it will be important to establish the nature and relationship of the various Sup35p 
oligomers present in the [PSI+] cell and the mechanism by which they are generated.  
Nevertheless, the in vitro studies provide us with strong clues to why the cellular levels of 
Hsp104 are critical for ensuring efficient prion propagation in non-stressed cells. It is 
conceivable that Hsp104 may in fact have a different function or mode of action in non-
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stressed cells that effectively propagate prions such as [PSI+], compared with stressed 
cells (54). 
 
What about mammalian prions? Higher eukaryotes, including mammals, encode various  
AAA+ proteins that share sequence features with the Hsp104/ClpB proteins. These 
include p97/VCP/Cdc48p which has a general chaperone-like function and participates in 
a number of different cellular processes (55), torsin A, an ER-lumenal protein implicated 
in torsion dystonia, a movement disorder, and SKD3, a 76kDa ATPase first identified in 
mouse macrophages (56). Although overexpression of both p97/VCP/Cdc48p (57) and 
torsin A (58) suppress the aggregation of non-transmissible polyglutamine aggregates, 
there are no data that  conclusively link the disaggregation properties of these proteins 
with the propagation of any neurodegenerative disease (12,59). Furthermore, the ability 
of p97/VCP/Cdc48p to bind to denatured proteins and maintain them in a soluble state, 
does not require p97/VCP/Cdc48p-associated ATPase activity (55) and is unable to 
promote Sup35pNM fibre disassembly in a reconstituted in vitro system (53). These 
findings may simply reflect a failure to recognise the heterologous substrate or, more 
likely, through a fundamental difference in the mode of action of p97/VCP/Cdc48p and 
Hsp104.  
 
It is important to remember that mammalian prions are largely associated with non-
dividing cells in the brain, whereas a yeast cell undergoes division every 2-3 hours 
without loss of the prion. Perhaps Hsp104 has co-evolved with prion-based epigenetic 
regulators of phenotype and has acquired specific functions that are lacking in other 
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related AAA+ ATPases, but which ensure rapid generation of new prion seeds to ensure 
efficient propagation of the prion in rapidly dividing cells? 
 
The interactions between a AAA+ protein and its substrate(s) are mediated largely 
through their N or C termini which either recognise the substrate directly or may bind 
‘adaptor’ proteins which in turn mediate substrate binding (60). Three yeast Hsp90-
binding co-chaperones, Sti1p, Cpr7p and Cns1p, interact with the C-terminus of Hsp104 
in respiring cells (17), but although both Sti1p and Cpr7p play a minor, non-essential role 
in [PSI+] propagation, this appears to be mediated via their regulation of the substrate 
binding properties of Ssa1p (Hsp70) rather than Hsp104 (61). 
 
Genetic studies using both native and artificially constructed yeast prions have 
demonstrated that, in addition to Hsp104, both Hsp70 (Ssa1/2p, Ssb1/2p) and Hsp40  
(Ydj1p, Sis1p) chaperones (see Table 1) are also components of the prion propagation 
machinery and work in conjunction with Hsp104 to generate new propagons (40,62, 
reviews) although no direct in vitro interaction, using purified proteins, has yet been 
reported.  
 
Hsp70:a key modulator of prion propagation? 
The Hsp70s are a highly conserved family of chaperones that form the central part of a 
ubiquitous protein folding system (10) and are also involved in aiding protein 
translocation across membranes, translation and regulation of the heat shock response 
(10, 63,64). The yeast genome encodes at least fourteen distinct Hsp70-related  proteins 
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that are located in various cellular compartments, but which all share the property of 
binding to short hydrophobic segments of partially folded or unfolded polypeptides 
thereby preventing their aggregation and hence aid correct folding. 
 
The Hsp70s consist of an amino-terminal ATPase domain that regulates the function of 
an adjacent peptide-binding domain, and a carboxyl-terminal variable domain. The finely 
tuned ATPase cycle of Hsp70 regulates the ability of the chaperone to bind non-
covalently to its substrate (Figure 3). When ATP is bound, the peptide-binding domain is 
in the “open” conformation and can rapidly bind and release the peptide substrate. ATP 
hydrolysis causes a conformational change to the “closed” form that establishes a tight 
association between Hsp70 and its substrate, while nucleotide exchange restores the ATP 
bound form and returns it to the “open” conformation. Various co-chaperones fine-tune 
the Hsp70 ATPase cycle (Figure 3) (65, review). 
  
Amino acid sequence divergence has allowed varying functions of Hsp70s to evolve. In 
addition, functional differences are achieved through interactions with different co-
chaperones and also through interaction with other non-Hsp70 chaperones. For instance, 
the ATPase activity of Ssa1p can be stimulated by both Sis1p and Ydj1p whereas Ssb1p 
cannot (66). For each cellular compartment in which Hsp70 resides, specific Hsp40 
partner(s) can be identified. 
 
Two sub-families of cytosolic Hsp70 have been implicated in yeast prion propagation;  
the Ssa (61, 67-72) and the Ssb sub-families (69,73,74). In addition to effects on prion 
 16
propagation, overexpression of Hsp70 can suppress the polyglutamine-associated 
pathogenicity and reduce the formation of the associated amyloid fibrils (reviewed in 75). 
Recently, a more tractable yeast model for the study of polyglutamine expansion diseases 
has been developed and has also implicated the Ssa family in regulating amyloid 
formation and toxicity in vivo (76). The Hsp70 family may therefore have a universal role 
in suppressing the formation of both transmissible and non-transmissible pathogenic 
aggregates. 
 
Over-expression of Ssa1p reduces the efficiency of curing of [PSI+] by Hsp104 over-
expression (67) and the complexity of the chaperone-prion interaction is highlighted by 
the differing abilities of combinations of over-expressed chaperones and co-chaperones to 
cure different strains and variants of [PSI+] (69). This most likely reflects underlying 
differences in structure of the prion oligomers that in turn affects the ability of the various 
chaperones to interact efficiently with the prion substrate. The complexity of the 
chaperone-prion interaction is further emphasised by the differing effects of over-
expression of Hsp104, Ssa1p and Ssa2p on [PSI+] and [URE3]; over-expression of 
Hsp104 can cure [PSI+] but does not cure [URE3] while over-expression of Ssa1p but not 
Ssa2p can cure [URE3]. Yet neither Ssa1p nor Ssa2p have any effect on [PSI+] when 
over-expressed in unstressed cells (41,42,70). 
 
If the non-essential Hsp70-Ssb family of chaperones is deleted in a [PIN+] background, 
the spontaneous level of [PSI+] appearance increases ten-fold, and the ability of Hsp104 
over-expression to eliminate [PSI+] is severely reduced in these cells (73). Over-
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expression of Ssb1p can also eliminate artificially constructed variants of [PSI+] (69,74). 
A possible explanation for these findings is that lack of Ssb leads to an increase in the de 
novo appearance of [PSI+] as a direct consequence of the loss of the Ssb-associated 
chaperone function needed to act on the ribosome-associated nascent polypeptide. 
Conversely, over-expression of Ssb may reduce the amount of newly synthesised Sup35 
that can be recruited into the prion form. 
 
An insight into how Hsp70-Ssa may influence prion propagation has come from the 
isolation of a novel SSA1 mutant (SSA1-21), that impairs [PSI+] propagation, reduces 
propagon number and, in cells where the encoded protein is the sole Ssa, [PSI+] cannot be 
maintained (68,71). Yet in spite of this clear effect on [PSI+] propagation, the SSA1-21 
mutation does not affect cell growth or Ssa1p function. The SSA1-21 mutation (L483W) 
creates a change in the peptide-binding domain of Ssa1p, but mapping of this residue 
onto the crystal structure of DnaK fails to give any clues as to what function of Hsp70 
may be affected (68). Eight additional SSA1 mutants with similar phenotypes to SSA1-21 
locate to the ATPase domain (71) suggesting that an alteration of the ATPase function of 
Ssa1p can alter prion propagation. It is conceivable that the Ssa1-21 protein has its effects 
by altering the communication between the ATPase and peptide-binding domains of the 
chaperone (68,71). 
 
The location of second-site suppressors of the SSA1-21 mutation in the ATPase and C-
terminal domains implicate Hsp40 and TPR co-chaperones in aiding Ssa1-21p impairing 
[PSI+] propagation, whereas those within the peptide-binding domain are located in 
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residues involved in regulating the substrate trapping mechanism of Hsp70 (71). That 
mutations that weaken the substrate binding properties of Ssa1p can suppress the SSA1-
21 mutation suggests that Ssa1-21p has enhanced substrate-binding properties. Therefore, 
by altering the finely tuned Hsp70 peptide binding cycle, prion propagation can be 
impaired. 
 
Hsp70 co-chaperones and yeast prion propagation  
The Ssa1p co-chaperones Ydj1p and Sis1p also play a role in yeast prion propagation as 
judged by monitoring the consequences of overexpression of the co-chaperone or by 
studying genetic interactions with the SSA1-21 allele. For example, over-expression of 
Ydj1p eliminates [URE3] (42) and certain variants of [PSI+] (69), while the over-
expression of Sis1p or Ydj1p, efficiently eliminate an “artificial” variant of [PSI+] (77). 
Since deletion of the non-essential YDJ1 gene enhances the effects of SSA1-21 on [PSI+] 
propagation, this indicates that the Sis1p:Ssa1p interactions might be crucial in [PSI+] 
propagation (71). Sis1p also plays a role in the propagation of the [RNQ+] prion through 
its interaction with Ssa1p (78,79). The ability of both Sis1p and Ydj1p to bind various 
peptide substrates and deliver them to Ssa1p is controlled via a common chaperone 
module within these proteins and by a region (the G/F region), adjacent to their putative 
peptide binding domains (78-82). 
 
Over-expression of Sti1p, the yeast homologue of the mammalian TPR co-chaperone 
Hop, also leads to loss of an “artificial” [PSI+] variant (77) and impairment of the 
propagation of a natural [PSI+] variant (61). Second-site intragenic suppressors of SSA1-
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21 that map to the conserved GPTVEEVD C-terminal motif of Ssa1p, suggest that a 
productive interaction between Ssa1p and TPR co-chaperones is required for the Hsp70-
mediated effects on [PSI+] (71). Although deletion of the non-essential genes encoding 
the TPR co-chaperones Sti1p and Cpr7p negates the effects of Ssa1-21p, deletion of the 
genes encoding two other TPR co-chaperones (Cpr6p or Sgt2p) does not. Furthermore, 
suppression of SSA1-21 by deletion of the CPR7 gene is reversed if the CNS1 gene is 
over-expressed in these cells. Therefore, for Ssa1-21p to alter prion propagation, a 
productive interaction with a sub-set of TPR co-chaperones is required (61). The effects 
on yeast prion propagation of over-expression of either TPR co-chaperones or Hsp40s 
suggests an Hsp70-dependent mechanism that involves the stimulation of Hsp70 ATPase 
activity and promotion of substrate binding. 
 
The finding that Ssa1-21p requires a productive interaction with TPR co-chaperones 
raises the possibility that chaperone complexes containing Hsp90 may be involved in 
prion propagation since Hsp90s also contain the highly conserved EEVD C-terminal 
motif in common with Hsp70s (83). However, over-expression of Hsp90 has no effect on 
prion propagation or curing by Hsp104, and the defects in prion propagation seen in the 
SSA1-21 mutant are not altered in strains expressing Hsp90 deleted for the C-terminal 
MEEVD domain (61,67). Perhaps it is the functional interaction between Hsp70 and the 
TPR co-chaperones that is independent of physical interactions between the TPR motif 
and the C-terminus of Hsp70 that is important for prion propagation? 
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Fes1p, a recently described nucleotide exchange factor for Ssa1p in both yeast (84) and 
humans (85), accelerates the release of ADP from substrate-bound Ssa1p (Figure 3) while 
Sti1p and Cns1p are activators of Ssa1p ATPase (86,87). In keeping with this 
antagonistic action to Hsp70 TPR co-chaperones, if FES1 is deleted in SSA1-21 cells then 
the [PSI+] prion is no longer propagated (61). Conversely, over-expression of FES1 in 
SSA1-21 cells produces a “stronger” [PSI+] phenotype (61). These data suggest that 
promotion of substrate binding by Hsp70 impairs [PSI+] propagation. 
 
The genetic data emerging suggest that in conjunction with a sub-set of co-chaperones, 
Hsp70 plays a central role in the propagation of yeast prions (Figure 4). This role 
involves the binding and release of a prion or prion-related substrate that is essential for 
the maintenance of the prion. In the same manner as Hsp70 interacts with denatured or 
partially folded polypeptides, the Hsp70-prion substrate interaction is finely balanced and 
linked to the Hsp70 ATPase cycle. 
 
Chaperones and mammalian prions? 
Given that the Hsp70 chaperones have been highly conserved through evolution, it is 
conceivable that the mammalian Hsp70 homologues may play a role in the propagation 
of the prion form of PrP. However, although it has been reported that BiP (a member of 
the Hsp70 family) is able to bind to mutant forms of PrP (88), the only chaperone that 
appears to facilitate the in vitro conversion of PrPC to a protease resistant form  is the 
bacterial chaperonin GroEL (89,90), but importantly this form has not been shown to be 
infectious. Other chaperones must also play a role in the correct folding of PrPC, for 
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example inhibition of Hsp90 by geldanamycin leads to a change in PrPC conformation 
and/or glycosylation (91). How prion seeds are generated in non-dividng cells is not 
known but their generation via a molecular chaperone-mediated process of aggregate 
dissociation is an attractive model and one that is made all the more attractive by the 
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Figure 1. Cooperative functions of Hsp104, Hsp70 and Hsp40 
When exposed to stress, such as heat-shock, proteins can become denatured or misfolded 
and form into amorphous aggregates. The action of Hsp104, aided by Hsp70 and Hsp40, 
results in a disaggregation of amorphous aggregates into substrates that Hsp70 and Hsp40 
can act upon and aid in their correct refolding. It is still unclear in what order these 
chaperones interact with the initial larger aggregate, and this order may well vary 
depending on size or other physical nature of the aggregate. 
 
Figure 2. Aggregation of GFP when fused to a yeast prion domain 
When the prion-forming domain (PrD) of a yeast prion protein is fused in-frame with 
Green Fluorescent Protein (GFP), the resulting GFP fusion protein will to coalesce into 
large aggregates if the cell already contains the prion form of the wild-type prion protein. 
In the example shown, the Sup35p-PrD –GFP fusion protein has been expressed in a 
[PSI+] strain and the resulting aggregates indicated by arrows.. 
 
Figure 3. Regulation of Ssa1p reaction cycle by co-chaperones.  
Substrate binding is finely tuned by hydrolysis of ATP and nucleotide exchange. 
Stimulation of Hsp70 ATPase has been demonstrated for Ydj1p, Sis1p, Sti1p and Cns1p. 
Genetic data suggest Cpr7p may also stimulate Hsp70 ATPase. Nucleotide exchange is 
facilitated by the action of Fes1p. 
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Figure 4. A model for the role of the Hsp40 and Hsp70 chaperones in yeast prion 
propagation.  
Once a prion has formed in S. cerevisiae, the chaperone functions of Hsp104 and Hsp70 
maintain the propagation of the infectious protein. Hsp104 is the key component in 
generating infectious prion seeds from pre-existing amyloid aggregates (see Figure 1). 
Hsp70 also affects the seed generation process, and appears to require interaction with 
Hsp40 and TPR co-chaperones to function in this capacity. The complex genetic 
behaviour of the various Hsp70s and their co-chaperones in prion propagation suggest 
that subtle differences in Hsp70 substrate recognition may be achieved by altering the 
composition of an Hsp70-Hsp40-Tpr complex. The nature of the Hsp40 and Tpr co-
chaperones interacting with a particular Hsp70 may also affect Hsp70 substrate 
preference in its function in the stress response. It is also conceivable that a preference 
exists between highly homologous cytosolic Hsp70s and the choice of Hsp40 and Tpr 
partners. The conserved nature of the majority of chaperones involved in prion 
propagation in yeast and their mammalian counterparts, suggests that a similar 
mechanism for PrPSc maintenance may exist. 
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Table 1: Major chaperone and co-chaperone families in the yeast cytosol 
Family Members General functions 
Hsp100a Hsp104 Protein disaggregation, stress tolerance. 
Hsp90b Hsc82, 
Hsp82 
Protein folding and stress tolerance. Most substrates appear to 





Protein folding and stress tolerance. Bind to denatured 
proteins and prevent aggregation. Also involved in aspects of 
protein translocation and translation. 
Hsp40c Ydj1p, 
Sis1p  
Deliver peptide substrates and stimulate ATPase activity of 








Aid in the Hsp70-Hsp90 protein folding cycle. Sti1p bridges 
Hsp70 to Hsp90 and regulates ATPase activity of both 
proteins. 
Small Hspsd Hsp26, 
Hsp42 





a Detailed review in Weibezahn et al. (12).  
b Detailed review in Wegele et al. (10). 
c Detailed review in Fan et al. (82).  
d Detailed review in Walter and Buchner (2) 
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